SCHEMBL5327271

SCHEMBL5327271

C[C@](N)(I)c1cccc(C(F)(F)F)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.52
MAPK1 P28482 1/20 0.52
HTR2A P28223 2/20 0.46
HTR2C P28335 2/20 0.46
HTR2B P41595 2/20 0.46
KIF11 P52732 1/20 0.45
TAAR1 Q96RJ0 1/20 0.44
IDO1 P14902 2/20 0.43
HTR3E A5X5Y0 1/20 0.43
HTR3B O95264 1/20 0.43
HTR3A P46098 1/20 0.43
HTR3D Q70Z44 1/20 0.43
HTR3C Q8WXA8 1/20 0.43
TACR1 P25103 1/20 0.42
CES2 O00748 1/20 0.42
MGLL Q99685 1/20 0.42
ALDH1A1 P00352 1/20 0.41
KDM1A O60341 2/20 0.41
NFE2L2 Q16236 1/20 0.41
PNMT P11086 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5323279 1.00 TSHR (0.52) TSHRMAPK1HTR2AHTR2CHTR2B
SCHEMBL23590587 1.00 TSHR (0.52) TSHRMAPK1HTR2AHTR2CHTR2B
SCHEMBL3168194 0.85 TSHR (0.58) TSHRMAPK1HTR2AHTR2CHTR2B
Methylamine SCHEMBL27581718 0.82 TSHR (0.65) TSHRMAPK1HTR2AHTR2CHTR2B
SCHEMBL26687550 0.79 KCNN4 (0.48) KIF11TAAR1IDO1NFE2L2
SCHEMBL27865869 0.79 TSHR (0.52) TSHRMAPK1HTR2AHTR2CHTR2B
SCHEMBL2635547 0.79 CES2 (0.47) TSHRMAPK1HTR2AHTR2CHTR2B
SCHEMBL3346352 0.79 CES2 (0.47) TSHRMAPK1HTR2AHTR2CHTR2B
SCHEMBL62723 0.79 TSHR (0.67) TSHRMAPK1HTR2AHTR2CHTR2B
SCHEMBL178282 0.78 TSHR (0.54) TSHRMAPK1HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1868434-A2 BETA-LACTAMYLALKANOIC ACIDS FOR TREATING PREMENSTRUAL DISORDERS Azevan Pharmaceuticals, Inc. (US) 2007-12-26 EP disclosed
WO-2007109615-A2 β -LACTAMYL VASOPRESSIN V2 ANTAGONISTS AZEVAN PHARMACEUTICALS, INC. (US) 2007-09-27 WO disclosed
WO-2006102283-A2 BETA-LACTAMYLALKANOIC ACIDS FOR TREATING PREMENSTRUAL DISORDERS AZEVAN PHARMACEUTICALS, INC. (US) 2006-09-28 WO disclosed
WO-2006102308-A2 BETA-LACTAMYL VASOPRESSIN V1B ANTAGONISTS AZEVAN PHARMACEUTICALS, INC. (US) 2006-09-28 WO disclosed